パズフロキサシン
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/02/26 14:32:09」(JST)
[Wiki en表示]
|
This article relies largely or entirely upon a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. (August 2014) |
Pazufloxacin
|
Systematic (IUPAC) name |
(3R)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-1H,7H- [1,3]oxazino[5,4,3-ij]quinoline-carboxylic acid |
Clinical data |
AHFS/Drugs.com |
International Drug Names |
Legal status |
?
|
Identifiers |
CAS number |
127046-18-8 Y |
ATC code |
J01MA18 |
PubChem |
CID 65957 |
ChemSpider |
59360 |
UNII |
4CZ1R38NDI Y |
Chemical data |
Formula |
C16H15FN2O4 |
Molecular mass |
318.29 g/mol |
SMILES
- C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O
|
InChI
-
InChI=1S/C16H15FN2O4/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)22/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)/t7-/m0/s1
Key:XAGMUUZPGZWTRP-ZETCQYMHSA-N
|
Y (what is this?) (verify) |
Pazufloxacin (INN) is a fluoroquinolone antibiotic.[1] It is sold in Japan under the brand names Pasil and Pazucross.
See also
References
- ^ Rubinstein, E. (2001). "History of quinolones and their side effects.". Chemotherapy. 47 Suppl 3: 3–8; discussion 44–8. doi:10.1159/000057838. PMID 11549783.
Antibacterials: nucleic acid inhibitors (J01E, J01M)
|
|
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis) |
DHFR inhibitor |
- 2,4-Diaminopyrimidine
- Trimethoprim#
- Brodimoprim
- Tetroxoprim
- Iclaprim†
|
|
Sulfonamides
(DHPS inhibitor) |
Short-
acting |
- Sulfaisodimidine
- Sulfamethizole
- Sulfadimidine
- Sulfapyridine
- Sulfafurazole
- Sulfanilamide
- Sulfathiazole
- Sulfathiourea
|
|
Intermediate-
acting |
- Sulfamethoxazole
- Sulfadiazine#
- Sulfamoxole
|
|
Long-
acting |
- Sulfadimethoxine
- Sulfadoxine
- Sulfalene
- Sulfametomidine
- Sulfametoxydiazine
- Sulfamethoxypyridazine
- Sulfaperin
- Sulfamerazine
- Sulfaphenazole
- Sulfamazone
|
|
Other/ungrouped |
- Sulfacetamide
- Sulfadicramide
- Sulfametrole
|
|
|
Combinations |
- Trimethoprim/sulfamethoxazole#
|
|
|
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication) |
1st g. |
- Cinoxacin‡
- Flumequine
- Nalidixic acid
- Oxolinic acid
- Pipemidic acid
- Piromidic acid
- Rosoxacin
|
|
Fluoro-
quinolones |
2nd g. |
- Ciprofloxacin#
- Enoxacin‡
- Fleroxacin‡
- Lomefloxacin
- Nadifloxacin
- Ofloxacin
- Norfloxacin
- Pefloxacin
- Rufloxacin
|
|
3rd g. |
- Balofloxacin
- Grepafloxacin‡
- Levofloxacin
- Pazufloxacin
- Sparfloxacin‡
- Temafloxacin‡
- Tosufloxacin
|
|
4th g. |
- Besifloxacin
- Clinafloxacin†
- Garenoxacin
- Gemifloxacin
- Moxifloxacin
- Gatifloxacin‡
- Sitafloxacin
- Trovafloxacin‡/Alatrofloxacin‡
- Prulifloxacin
|
|
Vet. |
- Danofloxacin
- Difloxacin
- Enrofloxacin
- Ibafloxacin
- Marbofloxacin
- Orbifloxacin
- Pradofloxacin
- Sarafloxacin
|
|
Related (DG) |
- Aminocoumarins: Novobiocin
|
|
|
|
Anaerobic DNA
inhibitors |
Nitro- imidazole derivatives |
- Metronidazole#
- Tinidazole
- Ornidazole
|
|
Nitrofuran derivatives |
- Nitrofurantoin#
- Furazolidone‡
- Nifurtoinol
|
|
|
RNA synthesis |
Rifamycins/
RNA polymerase |
- Rifampicin#
- Rifabutin
- Rifapentine
- Rifaximin
|
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of bacterial disease
|
|
Description |
|
|
Disease |
- Gram-positive firmicutes
- Gram-positive actinobacteria
- Gram-negative proteobacteria
- Gram-negative non-proteobacteria
- Cholera
- Tuberculosis
|
|
Treatment |
- Antibiotics
- cell wall
- nucleic acid
- mycobacteria
- protein synthesis
- Antibodies
- Vaccines
|
|
|
English Journal
- Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.
- Sun C1, Hao J2, Dou M3, Gong Y4.
- The Journal of antibiotics.J Antibiot (Tokyo).2015 May;68(5):313-7. doi: 10.1038/ja.2014.150. Epub 2014 Nov 5.
- Fluoroquinolones are antimicrobial agents that are widely used clinically, but the increasing resistance of Acinetobacter baumannii (A. baumannii) to these agents is a matter of concern. We investigated mutant prevention concentrations (MPCs) of three fluoroquinolones, levofloxacin (LVX), pazufloxac
- PMID 25351948
- Heterologous strategy enhancing the sensitivity of the fluorescence polarization immunoassay of clinafloxacin in goat milk.
- Chen J1, Shanin IA2,3, Lv S1, Wang Q4, Mao C5, Xu Z1, Sun Y1, Wu Q1, Eremin SA2,3, Lei H1.
- Journal of the science of food and agriculture.J Sci Food Agric.2015 Apr 23. doi: 10.1002/jsfa.7228. [Epub ahead of print]
- BACKGROUND: Clinafloxacin is used for the treatment of disease in food-producing animals, e.g. Brucella melitensis, which often occurs in goats; however, the clinafloxacin residue in goat milk may harm human health and result in the development of drug-resistant bacterial strains or allergies. Despi
- PMID 25914021
- Characterization of plasmid-mediated quinolone resistance determinants in Klebsiella pneumoniae and Escherichia coli from Tokai, Japan.
- Okade H1, Nakagawa S2, Sakagami T2, Hisada H2, Nomura N2, Mitsuyama J3, Yamagishi Y4, Mikamo H5.
- Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.J Infect Chemother.2014 Dec;20(12):778-83. doi: 10.1016/j.jiac.2014.08.018. Epub 2014 Sep 17.
- The spread of plasmid-mediated quinolone resistance (PMQR) determinants was evaluated in 150 ceftazidime or cefotaxime-resistant clinical isolates of Klebsiella pneumoniae and Escherichia coli from Tokai, Japan between 2008 and 2011. In this study, qnrB, qnrS, and aac(6')-Ib-cr genes were detected i
- PMID 25239060
Japanese Journal
- 重症熱性血小板減少症候群(SFTS)との鑑別を要した重症日本紅斑熱の 1 例
- Successful Additional Corticosteroid Treatment in a Patient with Mycoplasma pneumoniae Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid
- ニューキノロン系抗菌剤による即時型アレルギーの3例:―交差反応についての検討―
Related Links
- Pazufloxacin [PZFX] パズフロキサシン, ニューキノロン系 1. 商品名 先発品 パシル点滴静注液300mg/パシル点滴静注液500mg/パシル点滴静注液1000mg 【富山化学工業, 大正富山医薬品】 パズクロス注300/パズクロス注500 ...
- Pazufloxacin mesilate(PZFX)は富山化学工業(株)で創製 され,富山化学工業(株)と三菱ウェルファーマ(株)で共同 開発された注射用ニューキノロン系抗菌薬である。本薬は中 等症以上の感染症(肺炎,腎盂腎炎,胆嚢炎 ...
★リンクテーブル★
[★]
- 英
- pazufloxacin PZFX
- 同
- メシル酸パズフロキサシン pazufloxacin mesilate
- 商
- パシル、パズクロス
[★]
パズフロキサシン pazufloxacin